xl102
Showing 1 - 1 of 1
Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,
Recruiting
- Neoplasm Malignant
- +4 more
- XL102
- +3 more
-
Atlanta, Georgia
- +4 more
Apr 19, 2022